Management to host conference call and webcast today at 4:30 p.m. ET LEXINGTON, Mass., Nov. 6, 2025 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company ...
What we choose to study—whether fine art or finance—is one of the most influential decisions in our lives. It shapes not only ...
Highlights Third quarter 2025 revenue of $205.7 million decreased by 4% year-over-year but was flat when excluding previously discussed headwinds1 of $8.1 million, consistent with management ...
A newly identified disorder, MINA syndrome, results from a mutation in the NAMPT protein that deprives motor neurons of ...
With more than 250 peer-reviewed papers published in several high-impact journals, Katalin Susztak, MD, PhD, has opened the ...
Expanded Dose Exploration in Part A and Dose Escalation in Part B of BEAM-302 Phase 1/2 Study in Alpha-1 Antitrypsin ...
Received CTA authorization for Phase 1 trial of lead program AX-0810, targeting NTCP for cholestatic diseasesInitiating Phase ...
In the field of paediatrics, the concept of normal (ie, typical)—in contrast to different, special, deviant, delayed, or ...
In the wake of the certification of Macalester Undergraduate Workers Union-United Auto Workers (MUWU-UAW) in a landslide ...
BY JYOTHSNA HEGDE Padma Shri Dr. Dhananjay Diwakar Sagdeo, Chief Medical Officer of the Swami Vivekananda Medical Mission ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback